Conference

Neuroscience Education Institute (NEI) 2017 Congress

Neuroscience Education Institute (NEI) 2017 Congress
Influential leaders in the field of psychiatry will meet in Colorado Springs, Colorado, November 8-12, 2017, to discuss best practices for identifying and managing patients with mental illnesses. Sessions provide key takeaways for real-world clinical decisions to help improve patient outcomes. Sign up for our daily e-mail blasts on our registration page, and check back here during the conference for the full coverage.
November 13, 2017
Most studies on the potential of marijuana, classic hallucinogens, 3,4-methylenedioxymethamphetamine, and ketamine have been small with methodological flaws, but the promising results from existing studies suggest that larger studies are warranted, said William M. Suavé, MD, medical director, Greenbrook TMS NeuroHealth Centers, during a presentation on the therapeutic potential of illicit drugs.
November 13, 2017
During a session at the 2017 Neuroscience Education Institute (NEI) Congress, Ira D. Glick, MD, professor emeritus, Department of Psychiatry and Behavioral Sciences, Stanford School of Medicine, emphasized the importance of combining psychological and psychopharmacologic strategies for patients with Axis I disorders and provided guidelines for administering the combination.
November 12, 2017
Roger S. McIntyre, MD, FRCPC, professor, Departments of Psychiatry and Pharmacology, University of Toronto, and of the Head, Mood Disorders, Psychopharmacology Unit, University Health Network, discussed the contributing factors and effects of misdiagnosing or inappropriately treating patients with antidepressants.
November 12, 2017
During a session on distinguishing between bipolar disorder and attention-deficit/hyperactivity disorder, David W. Goodman, MD, FAPA, assistant professor, Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, and director and founder, Adult Attention Deficit Disorder Center of Maryland, explained that many of the symptoms for the 2 disorders overlap.
November 12, 2017
An economic analysis presented at the 2017 Neuroscience Educational Institute (NEI) Congress in Colorado Springs, Colorado, showed that pharmacogenomic testing in patients with specific psychiatric disorders can reduce the utilization of benzodiazepines.
November 11, 2017
A panel of doctors at the 2017 Neuroscience Education Institute (NEI) Congress discussed the impact of losing a patient to suicide and how they deal with it.
 
November 11, 2017
At the 2017 Neuroscience Education Institute (NEI) Congress, a Friday session focused on the physiology of fear and its impact on wellness. It was presented by Mary D. Moller, PhD, DNP, ARNP, PMHCNS-BC, CPRP, FAAN, associate professor, Pacific Lutheran University School of Nursing, and director of Psychiatric Services, Northwest Center for Integrated Health.
 
November 11, 2017
Exercise, diet, sleep, and hearing are 4 major factors that impact our aging, said Stephen M. Stahl, MD, PhD, adjunct professor of psychiatry, University of California San Diego during a session at the 2017 Neuroscience Educational Institute (NEI) Congress.
November 10, 2017
A session at the 2017 NEI Congress emphasized the importance of making an accurate diagnosis in patients presenting symptoms of depression.
 
November 10, 2017
Only 1 in 3 patients will achieve remission on their first antidepressant, and 67% of patients require 4 antidepressant trials before symptoms remit, said Thomas L. Schwartz, MD, during a session on strategies for switching, combining, or augmenting treatments for patients with major depressive disorder.
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.